🔗 Visit the ClinicalTrials.gov page for NCT00072020
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. | Lancet Oncol | 2014 | 1.92 |
| 2 | Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial. | BMC Cancer | 2013 | 0.95 |
| 3 | Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction. | Br J Cancer | 2010 | 0.91 |
| 4 | Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion. | Ther Adv Med Oncol | 2011 | 0.79 |
| 5 | Bisphosphonates: do we know their role in adjuvant breast cancer treatment? | Oncology (Williston Park) | 2010 | 0.75 |